STOCK TITAN

NuScale Power Corporation (SMR) DEF 14A Filings

SMR NYSE

Here are the DEF 14A proxy statements from NuScale Power Corporation (SMR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow SMR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SMR filings page.

Rhea-AI Summary

NuScale Power Corporation is asking stockholders to vote at its 2026 virtual annual meeting on May 29, 2026. Investors will elect nine directors, cast a non-binding advisory vote on executive compensation and ratify Ernst & Young LLP as auditor for the year ending December 31, 2026.

The proxy describes a majority-independent board, fully independent key committees and extensive nuclear and energy-sector expertise among directors and nominees. It also highlights a Tax Receivable Agreement tied to exchanges of NuScale Power, LLC Class B units, with an implied obligation of $582,178,000 and an estimated $365,000,000 payment in an early termination or change-of-control scenario.

Rhea-AI Summary

NuScale Power Corporation has called a virtual special stockholder meeting for December 16, 2025 to vote on a major share authorization change. The Board asks investors to approve an amendment to the certificate of incorporation that would increase authorized Class A common stock from 332,000,000 to 662,000,000 shares, raising total authorized capital stock to 842,000,000 shares. As of November 17, 2025, all 332,000,000 Class A shares were either issued or reserved, including 49,156,518 shares reserved for exchanges of Class B stock, equity plans and an at-the-market equity program.

The Board explains that NuScale has not yet commercialized its NuScale Power Module™ and currently relies on U.S. Department of Energy cost-sharing awards, a Romanian subcontract, and at-the-market stock sales to fund operations, and expects losses for the near to medium term. Management says additional authorized shares are needed to support capital raising, strategic deals and equity compensation. The filing highlights potential dilution and possible anti-takeover effects if more shares are issued, and cautions that failure to approve the increase could severely limit financing options and may create substantial doubt about NuScale’s ability to continue as a going concern.